Amino acid conjugation reaction, exogenous carboxylic acids are activated to form S-CoA derivatives in a reaction involving ATP and CoA (Figure 11 b)
Mild digestive changes (such as altered gut motility) are also common, though usually short-lived and tend to resolve as your body rebalances
Dual GIP/GLP-1 agonists may be better for patients who havent achieved sufficient weight loss with GLP-1 medications alone, those requiring more aggressive metabolic intervention, individuals who can tolerate the slightly higher side effect rates at maximum doses, and patients seeking the most effective currently available FDA-approved option
This post will explore the current scientific research regarding the link between GLP-1 medications and kidney health
Common side effects include: Gastrointestinal issues: Nausea, vomiting, constipation, and abdominal pain Injection site reactions: Redness, swelling, and pain Systemic issues: Fatigue, indigestion, heartburn, belching, and hair loss More severe side effects include: Thyroid problems: Medullary thyroid cancer and pancreatitis with severe, persistent abdominal pain Gallbladder problems with symptoms such as upper abdominal pain, fever, jaundice, or clay-colored stools Increased risk of hypoglycemia with symptoms such as dizziness, sweating, confusion, and shakiness Severe vomiting that leads to dehydration and kidney problems Mental health concerns such as depression and suicidal thoughts Vision changes from rapid changes in blood glucose levels Some patients should not use Zepbound, such as those who have or are at risk for medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2
